Placental Calcification on Ultrasound: What It Means
You were told you have placental calcification or a "Grade 3" placenta on ultrasound — how worried should you actually be?
It depends almost entirely on timing. Calcification is a normal, expected part of placental maturation, and by term most placentas show meaningful calcification without it meaning anything is wrong. The genuine area of concern is specifically calcification appearing earlier than expected — before roughly 34 to 36 weeks — and even there, the research linking it to complications is real but honestly inconsistent, complicated further by the grading system itself having documented reliability problems between different observers.
What does placental grading actually measure?
Placental calcification is graded using the Grannum system, a scale from 0 to III based on the appearance and location of calcium deposits visible on ultrasound, with higher grades reflecting more extensive calcification. It's worth knowing this system wasn't originally designed to detect placental insufficiency at all — it was developed decades ago as a substitute marker for fetal lung maturity, in an era before more direct testing was widely available. Its use as a marker of placental aging or dysfunction came later, and that origin is part of why its clinical role today is genuinely debated.
Why does the timing of the finding change everything?
Calcification is part of how a placenta normally ages throughout pregnancy — it's not inherently abnormal tissue, but a reflection of the placenta doing what placentas do as pregnancy progresses. By the time a pregnancy reaches term, some degree of calcification, often Grade 2 or even Grade 3, is common and expected in a healthy, normally functioning placenta. This is precisely why a calcification finding at 38 or 39 weeks and the same finding at 30 or 32 weeks carry very different weight — one is on-schedule maturation, the other is premature.
The research specifically distinguishes "premature placental calcification" (PPC) — Grade 3 calcification appearing before roughly 34 to 36 weeks — as the finding worth genuine attention, rather than calcification in general.
Is premature calcification actually linked to complications?
This is worth knowing plainly rather than glossing over: even premature calcification's clinical significance remains genuinely debated in the research. Several studies and at least one recent meta-analysis have found real associations between Grade 3 calcification before 36 weeks and outcomes including fetal growth restriction, preeclampsia, low Apgar scores, and stillbirth. But multiple other studies have failed to replicate these same associations, and the overall certainty of evidence has been rated low to moderate due to inconsistency between studies.
A meaningful part of why the evidence is so inconsistent may be the grading system itself. A study specifically examining how reliably different observers grade the same placenta found only fair agreement overall, and poor agreement specifically for Grade III — meaning two different sonographers or physicians looking at the same ultrasound images could reasonably disagree about the grade being assigned. When the underlying measurement itself isn't consistently reproducible, it's genuinely difficult for research studying that measurement to produce consistent findings, which likely explains at least part of why different studies reach different conclusions about calcification's predictive value.
What gives a more reliable picture of placental function?
Because of these real limitations, modern practice increasingly looks beyond calcification grading alone when there's genuine concern about placental function. Doppler ultrasound of the umbilical and uterine arteries measures actual blood flow resistance, providing a direct, more objective window into placental vascular function rather than a subjective visual grade. Serial growth scans, tracking fetal growth trajectory over multiple visits rather than a single measurement, are considerably more informative than one snapshot, since a single growth measurement can't distinguish a baby who's small but growing consistently from one whose growth is genuinely faltering. Newer biomarker approaches, including the ratio of placental growth factor (PlGF) to sFlt-1 in maternal blood, are also increasingly used to help clarify genuine placental dysfunction, particularly in the context of possible preeclampsia. Our piece on what you can still control with a high-risk pregnancy covers more about proactive monitoring options worth discussing with your care team.
What should you ask if you've been told this?
If calcification or a specific placental grade comes up at an appointment, a few direct questions are more useful than searching the term itself: what was your gestational age at the time of this finding, since that context changes everything; has growth trajectory been tracked over more than one visit, rather than relying on a single measurement; and have Doppler studies been done, or is this finding being considered on its own. A calcification finding in isolation, especially near term and without corroborating findings on growth or Doppler studies, carries considerably less weight than the phrase "placental insufficiency" tends to suggest. Metabolic factors also play a real role in placental vascular health more broadly — our piece on what gestational diabetes actually does to the placenta covers how the maternal metabolic environment reshapes placental blood vessels, and supporting a partner through gestational diabetes touches on the day-to-day side of managing it.
The Bottom Line
Placental calcification is a normal part of pregnancy that becomes a genuine area of clinical interest mainly when it appears earlier than expected — and even then, the evidence connecting it to real complications is honestly inconsistent, partly because the grading system itself has known reliability problems between observers. If this finding comes up, the more useful next questions are about timing, growth trajectory, and Doppler findings, not the grade number in isolation. Here in Huntington, we talk through exactly this kind of ultrasound-report anxiety with patients often, helping separate what genuinely warrants closer monitoring from what's simply normal placental aging. Our Metabolic & Immune Fertility Evaluation also addresses the metabolic factors that plausibly shape placental vascular health well before any ultrasound finding appears. Placental position raises a similar question — see whether an anterior placenta actually raises risk.
This article is for general educational purposes and isn't a substitute for individualized guidance from your OB-GYN or maternal-fetal medicine specialist. Any concerns about placental findings on ultrasound should be evaluated directly by your care team.
East to West Fertility is a metabolic and immune-focused fertility clinic in Huntington, Long Island, serving patients across Long Island, NYC, and beyond. Learn more about our Metabolic & Immune Fertility Evaluation or call 631-416-4940.
References:
- "The Association of Placental Grading with Perinatal Outcomes: A Systematic Review and Meta-Analysis." PMC12109751.
- "Impact of Placental Grading on Pregnancy Outcomes: A Retrospective Cohort Study." PMC11942256.
- Sau A, et al. "Intraobserver and interobserver variation in the sonographic grading of placental maturity." Ultrasound Obstet Gynecol, 2004.
- "Is Grannum Grading of the Placenta Reproducible?" University College Dublin research repository.
